The costimulatory molecule ICOS plays an important role in the immunopathogenesis of EAE

Nature Immunology

Volumn 2, Issue 7, 2001, Pages 605-611

  Rottman, James B ^a   Smith, Tammy ^a   Tonra, James R ^a   Ganley, Kenneth ^a   Bloom, Troy ^a   Silva, Robert ^a   Pierce, Barbara ^a   Gutierrez Ramos, Jose Carlos ^a   Özkaynak, Engin ^a   Coyle, Anthony J ^a  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CELL MARKER; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; LYMPHOCYTE ANTIGEN; MESSENGER RNA; PROTEOLIPID PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BRAIN; CELL CULTURE; CONTROLLED STUDY; DISEASE EXACERBATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INTERFERON PRODUCTION; LYMPHOCYTIC INFILTRATION; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD80; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BRAIN; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOGLOBULIN G; INTERFERON TYPE II; MICE; MYELIN PROTEOLIPID PROTEIN; T-LYMPHOCYTES; UP-REGULATION;

EID: 0034922160     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/89750     Document Type: Article

References (39)

1. CD28/B7 system of T cell costimulation
2. Blockade of CD28 during in vitro activation of encephalitogenic T cells or after disease onset ameliorates experimental autoimmune encephalomyelitis
3. CD28-deficient mice are highly resistant to collagen-induced arthritis
4. CD28 interactions with either CD80 or CD86 are sufficient to induce allergic airway inflammation in mice
5. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection
6. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4(+) T cells
7. T-cell co-stimulation through B7RP-1 and ICOS
8. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand
9. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses
10. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28
11. ICOS is critical for CD40-mediated antibody class switching
12. ICOS co-stimulatory receptor is essential for T-cell activation and function
13. ICOS is essential for effective T-helper-cell responses
14. Immunopathogenesis of multiple sclerosis
15. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent
16. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
17. Modulation of susceptibility and resistance to an autoimmune model of multiple sclerosis in prototypically susceptible and resistant strains by neutralization of interleukin-12 and interleukin-4, respectively
18. Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2
19. Synchronous synthesis of α-and β-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis
20. Enhancement of Th2 response in IL-6-deficient mice immunized with myellin oligodendrocyte glycoprotein
21. Autopathogenic T helper cell type I (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein
22. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes
23. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
24. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis
25. Opposing effects of CTLA4-Ig and anti-CD80 (B7-I) plus anti-CD86 (B7-2) on experimental allergic encephalomyelitis
26. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis
27. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis
28. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis
29. + T cell cytokine profile in experimental allergic encephalomyelitis
30. Chemokines in immune-mediated inflammation of the central nervous system
31. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation
32. Cultured rat microglia express functional β-chemokine receptors
33. Inhibition of murine neutrophil recruitment in vivo by CXC chemokine receptor antagonists
34. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: Roles of IL-6 in the activation and differentiation of autoreactive T cells
35. Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor
36. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1
37. Importance of ICOS-B7RP-1 co-stimulation in acute and chronic allograft rejection
38. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
39. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system